Rewriting the paradigm for IL4/STAT6 and th2 differentiation. New rules for in vivo commitment

被引：0
|
作者：
van Panhuy, Nicholas
Scarlet, Debbie
Camberis, Mali
Roberts, Joanna
Prout, Melanie
Tang, Schiau-Choot
Li, Jane Hu
Min, Booki
Paul, William
Le Gros, Graham
机构：
[1] Malaghan Inst Med Res, Wellington, New Zealand
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] NIAID, NIH, Immunol Lab, Bethesda, MD 20892 USA
来源：
CYTOKINE | 2007年 / 39卷 / 01期
关键词：
D O I：
10.1016/j.cyto.2007.07.164
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
159
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] Grail controls Th2 cell development by targeting STAT6 for degradation
    Sahoo, Anupama
    Alekseev, Andrei
    Obertas, Lidiya
    Nurieva, Roza
    NATURE COMMUNICATIONS, 2014, 5
  • [22] Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile
    Jankovic, D
    Kullberg, MC
    Noben-Trauth, N
    Caspar, P
    Paul, WE
    Sher, A
    JOURNAL OF IMMUNOLOGY, 2000, 164 (06): : 3047 - 3055
  • [23] POTENT AND SELECTIVE ORAL STAT6 DEGRADERS INHIBIT IL-4 AND IL-13 FUNCTIONS IUN HUMAN CELLS AND BLOCK TH2 INFLAMMATION IN VIVO IN A MOUSE MODEL
    Wang, Amy
    Yang, Bin
    Ramanathan, Anand
    Hossain, Alamgir
    Dong, Huijun
    Follows, Bruce
    Browne, Chris
    Harsch, Andreas
    Sawant, Rupa
    Enerson, Bradley E.
    Slavin, Anthony
    Mainolfi, Nello
    GASTROENTEROLOGY, 2024, 166 (05) : S1352 - S1352
  • [24] Interferon Gamma Inhibits Th2 Induced Mucus Metaplasia in vivo Through Effects on Epithelial IL-4 and IL-13 Receptor Expression, and Inhibition of Stat6 Phosphorylation
    Provost, K.
    Niu, N.
    Homer, R. J.
    Cohn, L. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [25] Probabilistic regulation of IL-4 production in Th2 cells: Accessibility at the Il4 locus
    Guo, LY
    Hu-Li, J
    Paul, WE
    IMMUNITY, 2004, 20 (02) : 193 - 203
  • [26] Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment
    Ouyang, WJ
    Löhning, M
    Gao, ZG
    Assenmacher, M
    Ranganath, S
    Radbruch, A
    Murphy, KM
    IMMUNITY, 2000, 12 (01) : 27 - 37
  • [27] Crosstalk between PKCζ and the IL4/Stat6 pathway during T-cell-mediated hepatitis
    Durán, A
    Rodriguez, A
    Martin, P
    Serrano, M
    Flores, JM
    Leitges, M
    Diaz-Meco, MT
    Moscat, J
    EMBO JOURNAL, 2004, 23 (23): : 4595 - 4605
  • [28] Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven TH2 cell response
    Wang, LH
    Yang, XY
    Kirken, RA
    Resau, JH
    Farrar, WL
    BLOOD, 2000, 95 (04) : 1249 - 1257
  • [29] An IL-4Rα allelic variant, I50, acts as a gain-of-function variant relative to V50 for Stat6, but not Th2 differentiation
    Stephenson, L
    Johns, MH
    Woodward, E
    Mora, AL
    Boothby, M
    JOURNAL OF IMMUNOLOGY, 2004, 173 (07): : 4523 - 4528
  • [30] RETRACTED: Punicalagin Alleviates Aged Bronchial Asthma by Inhibiting Th2 Differentiation through IL-4/STAT6 and Jagged1/Notch Pathways (Retracted Article)
    Yu, Li
    Li, Jianying
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
12345